[Federal Register Volume 81, Number 217 (Wednesday, November 9, 2016)]
[Notices]
[Pages 78804-78806]
[FR Doc No: 2016-26993]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings

    Take notice that the Commission has received the following Natural
Gas Pipeline Rate and Refund Report filings:

Filings Instituting Proceedings

    Docket Numbers: RP17-132-000.
    Applicants: Equitrans, L.P.
    Description: Compliance filing Operational Purchases and Sales
Report for 2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5035.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-133-000.
    Applicants: Northern Border Pipeline Company.

    Description: Sec.  4(d) Rate Filing: James Valley Ethanol Neg Rate
Agmt to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5036.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-134-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--BUG Releases
eff 11-1-2016 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5047.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-135-000.
    Applicants: Equitrans, L.P.
    Description: Sec.  4(d) Rate Filing: Negotiated Capacity Release
Agreements--11/1/2016 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5051.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-136-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Superseding NC Agmt Filing
(Atmos 21789) to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5056.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-137-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: NSAP Project-related
Negotiated Rate Agmts to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5058.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-138-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Neg Rate Agmt Filing (Tenaska
35784) to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5059.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-139-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Housekeeping Matters to be
effective 12/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5061.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-140-000.
    Applicants: Texas Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Neg Rate Agmt Filing (Midwest
Natural 35495) to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5062.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-141-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate--ConEd Release
to Trident to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5067.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-142-000.
    Applicants: Columbia Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: OTRA--Winter 2016 to be
effective 12/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5081.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-143-000.
    Applicants: Gulf South Pipeline Company, LP.
    Description: Sec.  4(d) Rate Filing: 2016 Fuel Tracker Filing
(Initial Filing) to be effective 4/1/2017.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5089.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-144-000.
    Applicants: Rockies Express Pipeline LLC.
    Description: Sec.  4(d) Rate Filing: Neg Rate 2016-11-01 Encana, CP
to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5091.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-145-000.
    Applicants: Rockies Express Pipeline LLC.
    Description: Compliance filing Neg Rates many Ks Capacity
Enhancement Compliance CP15-137 to be effective 12/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5106.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-146-000.
    Applicants: Kern River Gas Transmission Company.
    Description: Sec.  4(d) Rate Filing: 2017 May Period Two Rate to be
effective 5/1/2017.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5107.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-147-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--Plymouth
792512 & So Jersey 792522 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5110.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-148-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--IDT Ramapo
Releases eff 11-1-2016 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5111.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-149-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--Plymouth
Rock Ramapo Releases eff 11-1-2016 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5112.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-150-000.
    Applicants: Texas Eastern Transmission, LP.
    Description: Sec.  4(d) Rate Filing: Negotiated Rates--ConEd Nov
2016 Release to Entrust 8943503 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5150.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-151-000.
    Applicants: ANR Pipeline Company.
    Description: Sec.  4(d) Rate Filing: 3 Amended Negotiated Rate
Agreements to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5186.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-152-000.
    Applicants: Dauphin Island Gathering Partners.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate Filing 11-1-
2016 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5201.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-153-000.
    Applicants: Algonquin Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate--BUG Release
to Trident eff 11-2-16 to be effective 11/2/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5202.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-154-000.
    Applicants: Enable Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate Filing--
November 2016 LER 1008744 Removal to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5203.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-155-000.

    Applicants: Enable Gas Transmission, LLC.
    Description: Sec.  4(d) Rate Filing: Negotiated Rate Filing--
November 2016 Trans Louisiana 1010877 to be effective 11/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5209.
    Comments Due: 5 p.m. ET 11/14/16.

    Docket Numbers: RP17-156-000.
    Applicants: Rockies Express Pipeline LLC.
    Description: Compliance filing Capacity Enhancement Compliance to
be effective 12/1/2016.
    Filed Date: 11/1/16.
    Accession Number: 20161101-5210.
    Comments Due: 5 p.m. ET 11/14/16.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and Sec.  385.214) on or
before 5:00 p.m. Eastern time on the specified comment date. Protests
may be considered, but intervention is necessary to become a party to
the proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated November 2, 2016.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2016-26993 Filed 11-8-16; 8:45 am]
 BILLING CODE 6717-01-P


[Federal Register: May 14, 2010 (Volume 75, Number 93)]
[Notices]
[Page 27381-27383]
[DOCID:fr14my10-116]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-62054; File No. SR-NYSEArca-2010-34]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change To Adopt Commentary
.02 to Rule 5.32, Terms of FLEX Options, to Establish a Pilot Program
To Permit FLEX Options to Trade With no Minimum Size Requirement

May 6, 2010.
    Pursuant to Section 19(b)(1) of the Securities Exchange Act of 1934
(``Act'') \1\, and Rule 19b-4 \2\ thereunder, notice is hereby given
that on April 29, 2010, NYSE Arca, Inc. (``NYSE Arca'' or the
``Exchange'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I and II
below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C. 78s(b)(1).
    \2\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to adopt Commentary .02 to Rule 5.32, Terms
of FLEX Options, to establish a Pilot Program to permit FLEX Options to
trade with no minimum size requirement. The text of the proposed rule
change is attached as Exhibit 5 to the 19b-4 form. A copy of this
filing is available on the Exchange's Web site at http://www.nyse.com,
at the Exchange's principal office, at the Commission's Public
Reference Room, and on the Commission's Web site at http://www.sec.gov.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The purpose of the filing is to adopt rules to establish a Pilot
Program to eliminate minimum value sizes for both FLEX Equity options
and FLEX Index options similar to a pilot approved for the Chicago
Board Options Exchange (``CBOE'').\3\
---------------------------------------------------------------------------

    \3\ See Exchange Act Release No. 34-61439 (January 28, 2010) 75
FR 5831 (February 4, 2010).
---------------------------------------------------------------------------

    Presently, the Exchange minimum value size requirements for an
opening FLEX Equity transaction in any FLEX series in which there is no
open interest

at the time the Request for Quote is submitted is the lesser of 250
contracts or the number of contracts overlying $1 million in underlying
securities. An opening FLEX Index transaction in a FLEX series in which
there is no open interest requires a minimum size of $10 million
Underlying Equivalent Value. The Exchange proposes to adopt a fourteen
month pilot program that eliminates the minimum value size requirements
for both FLEX Equity and FLEX Index options. If, in the future, the
Exchange proposes an extension of the minimum value size Pilot Program,
or should the Exchange propose to make the new Program permanent, the
Exchange will submit, along with any filing proposing such amendments
to the Program, a Pilot Program report that would provide an analysis
of the Pilot covering the period during which the Program was in
effect. This minimum value size report would include: (i) Data and
analysis on the open interest and trading volume in (a) FLEX Equity
Options with opening transaction with a minimum size of 0 to 249
contracts and less than $1 million in underlying value; (b) FLEX Index
Options with opening transaction with a minimum opening size of less
than $10 million in underlying equivalent value; and (ii) analysis on
the types of investors that initiated opening FLEX Equity and Index
Options transactions (i.e., institutional, high net worth, or retail).
The report would be submitted to the Commission at least two months
prior to the expiration date of the Pilot Program and would be provided
on a confidential basis.
    The Exchange notes that any positions established under this Pilot
would not be affected by the expiration of the Pilot. For example, a
10-contract FLEX Equity Option opening position that overlies less than
$1 million in the underlying security and expires in January 2015 could
be established during the 14-month Pilot. If the Pilot Program were not
extended, the position would continue to exist and any further trading
in the series would be subject to the minimum value size requirements
for continued trading in that series. The proposed minimum opening
transaction size elimination is based on a similar pilot approved for
use on CBOE.\4\
---------------------------------------------------------------------------

    \4\ See Note 3 above.
---------------------------------------------------------------------------

2. Statutory Basis
    The Exchange believes the proposed rule change is consistent with
Section 6(b) \5\ of the Securities Exchange Act of 1934 (the ``Act''),
in general, and furthers the objectives of Section 6(b)(5) \6\ in
particular in that it is designed to promote just and equitable
principles of trade, to prevent fraudulent and manipulative acts, to
remove impediments to and to perfect the mechanism for a free and open
market and a national market system and, in general, to protect
investors and the public interest by eliminating a minimum size for
FLEX transactions, which the Exchange believes will provide greater
opportunities for investors to manage risk through the use of FLEX
options.
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78f(b).
    \6\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the foregoing proposed rule change does not: (1)
Significantly affect the protection of investors or the public
interest; (2) impose any significant burden on competition; and (3)
become operative for 30 days from the date on which it was filed, or
such shorter time as the Commission may designate if consistent with
the protection of investors and the public interest, it has become
effective pursuant to Section 19(b)(3)(A) of the Act \7\ and Rule 19b-
4(f)(6) thereunder.\8\
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(3)(A).
    \8\ 17 CFR 240.19b-4(f)(6). When filing a proposed rule change
pursuant to Rule 19b-4(f)(6) under the Act, an Exchange is required
to give the Commission written notice of its intent to file the
proposed rule change, along with a brief description and text of the
proposed rule change, at least five business days prior to the date
of filing of the proposed rule change, or such shorter time as
designated by the Commission. The Exchange has met this requirement.
---------------------------------------------------------------------------

    A proposed rule change filed under Rule 19b-4(f)(6) normally may
not become operative prior to 30 days after the date of filing.\9\
However, Rule 19b-4(f)(6) \10\ permits the Commission to designate a
shorter time if such action is consistent with the protection of
investors and the public interest. NYSE Arca has requested that the
Commission waive the 30-day operative delay.
---------------------------------------------------------------------------

    \9\ 17 CFR 240.19b-4(f)(6)(iii).
    \10\ Id.
---------------------------------------------------------------------------

    The Commission has considered NYSE Arca's request to waive the 30-
day operative delay. Because, however, the Commission does not believe,
practically speaking, that a pilot should retroactively commence, the
Commission is only waiving the operative delay as of the date of this
notice for the reasons discussed below.
    The Commission believes that shortening the 30-day operative delay
to allow the commencement of the pilot as of the date of this notice is
consistent with the protection of investors and the public interest.
The Commission notes that the proposed rule change is substantially
similar to a pilot that was previously approved by the Commission and
is currently in existence for CBOE.\11\ The Commission also notes that
the corresponding CBOE pilot was subject to full notice and comment in
the Federal Register, and that the Commission only received comments
that supported that proposal.\12\ Moreover, waiving the operative date
as of the date of this notice is consistent with approval of CBOE's
pilot, which allowed implementation as of the date of the Commission's
approval order. For these reasons, the Commission designates the
proposal to be operative upon the date of issuance of this notice.\13\
---------------------------------------------------------------------------

    \11\ See CBOE Rule 24A.4 Interpretations and Policies .01(b);
see also Securities Exchange Act Release No. 61439 (January 28,
2010) 75 FR 5831 (February 4, 2010) (SR-CBOE-2009-087).
    \12\ See Securities Exchange Act Release No. 61439 (January 28,
2010) 75 FR 5831 (February 4, 2010) (SR-CBOE-2009-087).
    \13\ For the purposes only of waiving the operative date of this
proposal, the Commission has considered the proposed rule's impact
on efficiency, competition, and capital formation. See 15 U.S.C.
78c(f).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in the furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://
www.sec.gov/rules/sro.shtml); or
     Send an e-mail to<EMAIL_ADDRESS>Please include
File Number SR-NYSEArca-2010-34 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to File Number SR-NYSEArca-2010-34. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/
rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for Web site
viewing and printing in the Commission's Public Reference Room, 100 F
Street, NE., Washington, DC 20549, on official business days between
the hours of 10 a.m. and 3 p.m. Copies of the filing also will be
available for inspection and copying at the principal office of the
Exchange. All comments received will be posted without change; the
Commission does not edit personal identifying information from
submissions. You should submit only information that you wish to make
available publicly. All submissions should refer to File Number SR-
NYSEArca-2010-34 and should be submitted on or before June 4, 2010.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\14\
---------------------------------------------------------------------------

    \14\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Elizabeth M. Murphy,
Secretary.
[FR Doc. 2010-11542 Filed 5-13-10; 8:45 am]
BILLING CODE 8010-01-P


[Federal Register Volume 77, Number 157 (Tuesday, August 14, 2012)]
[Notices]
[Pages 48608-48609]
[FR Doc No: 2012-19940]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

National Highway Traffic Safety Administration

[U.S. DOT Docket No. NHTSA-2012-0094]

Reports, Forms, and Record Keeping Requirements

AGENCY: National Highway Traffic Safety Administration (NHTSA), DOT.

ACTION: Request for public comment on proposed collection of
information.

-----------------------------------------------------------------------

SUMMARY: Before a Federal agency can collect certain information from
the public, it must receive approval from the Office of Management and
Budget (OMB). Under procedures established by the Paperwork Reduction
Act of 1995, before seeking OMB approval, Federal agencies must solicit
public comment on proposed collections of information, including
extensions and reinstatements of previously approved collections.
    This document describes the collection of information for which
NHTSA intends to seek OMB approval.

DATES: Comments must be received on or before October 15, 2012.

ADDRESSES: You may submit comments identified by DOT Docket ID Number
NHTSA-2012-0094 using any of the following methods:
    Electronic submissions: Go to http://www.regulations.gov. Follow
the on-line instructions for submitting comments.
    Mail: Docket Management Facility, M-30, U.S. Department of
Transportation, 1200 New Jersey Avenue SE., West Building Ground Floor,
Room W12-140, Washington, DC 20590.
    Hand Delivery: West Building Ground Floor, Room W12-140, 1200 New
Jersey Avenue SE., Washington, DC, between 9 a.m. and 5 p.m., Monday
through Friday, except Federal holidays.
    Fax: 1-202-493-2251.
    Instructions: Each submission must include the Agency name and the
Docket number for this Notice. Note that all comments received will be
posted without change to http://www.regulations.gov including any
personal information provided.

FOR FURTHER INFORMATION CONTACT: Mr. Alan Block, Contracting Officer's
Technical Representative, Office of Behavioral Safety Research (NTI-
131), National Highway Traffic Safety Administration, 1200 New Jersey
Avenue SE., W46-499, Washington, DC 20590. Mr. Block's phone number is
202-366-6401 and his email address is<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995,
before an agency submits a proposed collection of information to OMB
for approval, it must publish a document in the Federal Register
providing a 60-day comment period and otherwise consult with members of
the public and affected agencies concerning each proposed collection of
information. The OMB has promulgated regulations describing what must
be included in such a document. Under OMB's regulations (at 5 CFR
1320.8(d)), an agency must ask for public comment on the following:
    (I) Whether the proposed collection of information is necessary for
the proper performance of the functions of the agency, including
whether the information will have practical utility;
    (ii) The accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
    (iii) How to enhance the quality, utility, and clarity of the
information to be collected; and
    (iv) How to minimize the burden of the collection of information on
those who are to respond, including the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
    In compliance with these requirements, NHTSA asks public comment on
the following proposed collection of information:

Survey of DWI Courts

    Type of Request--New information collection requirement.
    OMB Clearance Number--None.
    Form Number--NHTSA 1175.
    Requested Expiration Date of Approval--3 years from date of
approval.
    Summary of the Collection of Information--The National Highway
Traffic Safety Administration (NHTSA) proposes to collect information
from specialized (or problem solving) courts known as DWI Courts and
Hybrid DWI/Drug Courts to obtain an inventory of their current
operational practices. All known operating DWI Courts and Hybrid DWI/
Drug Courts will be contacted by mail and/or email and asked to go to a
designated Web site to fill out the questionnaire. The most recent
figures (from the National Association of Drug Court Professionals
(NADCP)) show 598 Courts operating in the United States that are either
designated DWI Courts (192) or else Hybrid DWI/Drug Courts (406) as of
December 2010. That number is projected to increase to approximately
650 Courts by the time the survey is ready to enter the field. The
survey will ask about case flow, eligibility criteria, management
information systems, program staffing, treatment, testing, courtroom
practices, sanctions, and other relevant program characteristics. The
average amount of time for respondents to complete the survey is
estimated to be 40 minutes.
    The survey will be conducted on-line, with the on-line technology
serving to reduce length and minimize recording errors. No information
will be collected that could be used to identify any clients
participating in the court programs. The information provided will
either describe program practices/characteristics, or provide
information aggregated across all cases.
    Description of the Need for the Information and Proposed Use of the
Information--NHTSA was established to reduce the number of deaths,
injuries, and economic losses resulting from motor vehicle crashes on
the Nation's highways. As part of this statutory mandate, NHTSA is
authorized to conduct research as a foundation for the development of
motor vehicle standards and traffic safety programs.
    DWI Courts are a relatively new intervention to combat alcohol-
impaired driving and are authorized under MAP-21, the current DOT
authorization. Borrowing from the Drug Court Model, they are directed
at repeat offenders and offenders having high blood alcohol
concentration levels (BACs) at time of arrest. These Courts attack the
source of the problem by taking a comprehensive approach to changing
behavior that includes treatment. There is a body of research that now
exists to show that Drug Courts are effective. However, Drug Courts and
DWI Courts may treat different populations, and questions about the
effectiveness of DWI Courts and their services have yet to be
adequately answered. NHTSA is presently designing a program to evaluate
DWI Courts to directly answer key questions pertaining to their
effectiveness. But in order to do that, the agency first needs detailed
information on how the DWI Courts are operating.
    NHTSA will use the findings from this proposed collection of
information to guide the design of an evaluation program to answer key
questions regarding the effectiveness of DWI Courts.
    Description of the Likely Respondents (Including Estimated Number,
and Proposed Frequency of Response to the

Collection of Information)--The respondents will be people involved in
the running of DWI Courts and Hybrid DWI/Drug Courts. These primarily
will be Judges and Court Staff, but may include others involved in
specific aspects of the DWI Court program such as treatment providers,
law enforcement and probation/parole personnel. Contacted Courts will
determine who is appropriate to complete the sections of the
questionnaire, and may apportion different sections to different people
to complete, if necessary. The projected total number of DWI Courts and
Hybrid Courts at the commencement of the field period is 650. Total
estimated time to complete the questionnaire is expected to average 40
minutes. All Courts will be administered the survey one time only.
    Estimate of the Total Annual Reporting and Record Keeping Burden
Resulting from the Collection of Information--NHTSA estimates that the
Courts would require an average of 40 minutes to complete the survey or
a total of 433.33 hours for the projected 650 DWI and Hybrid Courts.
The survey would be fielded during a two month period in 2013. Thus the
annual reporting burden would be the entire 433.33 hours. Reporting
costs would entail salaried time for responding to the questionnaire.
Mean hourly wages for legal occupations range from $21.56 for legal
support workers to $53.34 for Judges, Magistrate Judges, and
Magistrates. At 433.33 total responding hours for the survey, this
would put the cost burden at a level between $9,343 and $23,114,
depending on which Court personnel respond to the survey. The
respondents would not incur any record keeping burden or record keeping
cost from the information collection.

    Authority: 44 U.S.C. Section 3506(c)(2)(A)

    Issued on: August 9, 2012.
Jeffrey Michael,
Associate Administrator, Research and Program Development.
[FR Doc. 2012-19940 Filed 8-13-12; 8:45 am]
BILLING CODE 4910-59-P


[Federal Register Volume 77, Number 180 (Monday, September 17, 2012)]
[Notices]
[Pages 57166-57167]
[FR Doc No: 2012-22725]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-67797; File No. SR-NYSEArca-2012-85]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change Amending Certain
NYSE Arca Equities Rules To Replace References to ``NYSE Amex'' With
``NYSE MKT'' Reflecting the Recent Name Change of NYSE Amex LLC to NYSE
MKT LLC

September 7, 2012.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby
given that, on August 28, 2012, NYSE Arca, Inc. (the ``Exchange'' or
``NYSE Arca'') filed with the Securities and Exchange Commission (the
``Commission'') the proposed rule change as described in Items I, II,
and III below, which Items have been prepared by the self-regulatory
organization. The Commission is publishing this notice to solicit
comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C.78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4.
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    The Exchange proposes to amend certain NYSE Arca Equities rules to
replace references to ``NYSE Amex'' with ``NYSE MKT'' to reflect the
recent name change of NYSE Amex LLC to NYSE MKT LLC. The text of the
proposed rule change is available on the Exchange's Web site at
www.nyse.com, at the principal office of the Exchange, and at the
Commission's Public Reference Room.

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the self-regulatory organization
included statements concerning the purpose of, and basis for, the
proposed rule change and discussed any comments it received on the
proposed rule change. The text of those statements may be examined at
the places specified in Item IV below. The Exchange has prepared
summaries, set forth in sections A, B, and C below, of the most
significant parts of such statements.

A. Self-Regulatory Organization's Statement of the Purpose of, and the
Statutory Basis for, the Proposed Rule Change

1. Purpose
    The Exchange proposes to amend certain NYSE Arca Equities rules to
replace references to ``NYSE Amex'' with ``NYSE MKT'' to reflect the
recent name change of NYSE Amex LLC to NYSE MKT LLC.\4\
---------------------------------------------------------------------------

    \4\ See Securities Exchange Act Release No. 67037 (May 21,
2012), 77 FR 31415 (May 25, 2012) (SR-NYSEAmex-2012-32).
---------------------------------------------------------------------------

    The Exchange proposes to replace references to NYSE Amex in NYSE
Arca Equities Rules 5.2(b), 5.5(a), 7.31, and 7.45 with references to
NYSE MKT. The Exchange also proposes to replace references to American
Stock Exchange, a predecessor of NYSE Amex, in NYSE Arca Equities Rules
5.2(d) and 5.2(e) with references to NYSE MKT.
2. Statutory Basis
    The Exchange believes that the proposed rule change is consistent
with Section 6(b) of the Securities Exchange Act of 1934 (the
``Act''),\5\ in general, and Section 6(b)(5) of the Act,\6\ in
particular, in that it is designed to prevent fraudulent and
manipulative acts and practices, to promote just and equitable
principles of trade, to foster cooperation and coordination with
persons engaged in facilitating transactions in securities, to remove
impediments to and perfect the mechanism of a free and open market and
a national market system and, in general, to protect investors and the
public interest. The proposed rule change would add clarity to the
Exchange's rules by correctly reflecting the current name of NYSE MKT,
which is in the public interest.
---------------------------------------------------------------------------

    \5\ 15 U.S.C. 78f(b).
    \6\ 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purposes of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants, or Others

    No written comments were solicited or received with respect to the
proposed rule change.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    The Exchange has filed the proposed rule change pursuant to Section
19(b)(3)(A)(iii) of the Act \7\ and Rule 19b-4(f)(6) thereunder.\8\
Because the proposed rule change does not: (i) Significantly affect the
protection of investors or the public interest; (ii) impose any
significant burden on competition; and (iii) become operative prior to
30 days from the date on which it was filed, or such shorter time as
the Commission may designate, if consistent with the protection of
investors and the public interest, the proposed rule change has become
effective pursuant to Section 19(b)(3)(A) of the Act and Rule 19b-
4(f)(6)(iii) thereunder.
---------------------------------------------------------------------------

    \7\ 15 U.S.C. 78s(b)(3)(A)(iii).
    \8\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of such proposed rule
change, the Commission summarily may temporarily suspend such rule
change if it appears to the Commission that such action is necessary or
appropriate in the public interest, for the protection of investors, or
otherwise in furtherance of the purposes of the Act.

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views, and
arguments concerning the foregoing, including whether the proposed rule
change is consistent with the Act. Comments may be submitted by any of
the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml); or
     Send an email to<EMAIL_ADDRESS>Please include
File Number SR-NYSEARCA-2012-85 on the subject line.

Paper Comments

     Send paper comments in triplicate to Elizabeth M. Murphy,
Secretary, Securities and Exchange Commission, 100 F Street NE.,
Washington, DC 20549-1090.

    All submissions should refer to File Number SR-NYSEARCA-2012-85.
This file number should be included on the subject line if email is
used. To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro.shtml). Copies of the submission, all subsequent amendments,
all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for Web site
viewing and printing in the Commission's Public Reference Section, 100
F Street NE., Washington, DC 20549-1090. Copies of the filing will also
be available for inspection and copying at the NYSE's principal office
and on its Internet Web site at www.nyse.com. All comments received
will be posted without change; the Commission does not edit personal
identifying information from submissions. You should submit only
information that you wish to make available publicly. All submissions
should refer to File Number SR-NYSEARCA-2012-85 and should be submitted
on or before October 9, 2012.

    For the Commission, by the Division of Trading and Markets,
pursuant to delegated authority.\9\
---------------------------------------------------------------------------

    \9\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Kevin M. O'Neill,
Deputy Secretary.
[FR Doc. 2012-22725 Filed 9-14-12; 8:45 am]
BILLING CODE 8011-01-P


[Federal Register Volume 77, Number 38 (Monday, February 27, 2012)]
[Notices]
[Pages 11555-11556]
[FR Doc No: 2012-4425]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2009-D-0605]

Guidance for Institutional Review Boards, Clinical Investigators,
and Sponsors: Institutional Review Board Continuing Review After
Clinical Investigation Approval; Availability

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is announcing the
availability of a guidance entitled, ``Guidance for IRBs, Clinical
Investigators, and Sponsors: IRB Continuing Review after Clinical
Investigation Approval.'' The guidance announced in this document
finalizes the draft guidance of the same title dated January 2010. This
document also supersedes the Information Sheet, Continuing Review After
Study Approval. The guidance is intended to assist institutional review
boards (IRBs) in carrying out their continuing review responsibility by
providing recommendations regarding the criteria, process, and
frequency of continuing review to assure the protection of the rights
and welfare of subjects in clinical investigations.

DATES: Submit either electronic or written comments at any time. Submit
electronic comments to http://www.regulations.gov. Submit written
comments on the guidance to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852. See the SUPPLEMENTARY INFORMATION section for
electronic access to the guidance document.

ADDRESSES: Submit written requests for single copies of this guidance
to the Division of Drug Information, Center for Drug Evaluation and
Research (CDER), Food and Drug Administration, 10903 New Hampshire
Ave., Bldg. 51, Rm. 2201, Silver Spring, MD 20993-0002 (1-888-463-6332
or<PHONE_NUMBER>); or the Office of Communication, Outreach and
Development (HFM-40), Center for Biologics Evaluation and Research
(CBER), Food and Drug Administration, 1401 Rockville Pike, Suite 200N,
Rockville, MD 20852-1448 (1-800-835-4709 or<PHONE_NUMBER>); or the
Division of Small Manufacturers, International, and Consumer
Assistance, Center for Devices and Radiological Health (CDRH), Food and
Drug Administration, 10903 New Hampshire Ave., Bldg. 66, Rm. 4613,
Silver Spring, MD 20993 (1-800-638-2041 or<PHONE_NUMBER>). Send one
self-addressed adhesive label to assist the office in processing your
requests.

FOR FURTHER INFORMATION CONTACT: Sara Goldkind, Office of Good Clinical
Practice, Food and Drug Administration, 10903 New Hampshire Ave., Bldg.
32, Rm. 5129, Silver Spring, MD 20993-0002.<PHONE_NUMBER>.

SUPPLEMENTARY INFORMATION:

I. Background

    FDA is announcing the availability of a guidance entitled,
``Guidance for IRBs, Clinical Investigators, and Sponsors: IRB
Continuing Review after Clinical Investigation Approval.'' This
guidance is intended to assist IRBs in carrying out their continuing
review responsibility under 21 CFR 56.108(a) and 56.109(f) by providing
recommendations regarding the criteria, process, and frequency of
continuing review to assure the protection of the rights and welfare of
subjects in clinical investigations. The guidance should also help
clinical investigators and sponsors better understand their
responsibilities related to continuing review. This guidance supersedes
the Information Sheet, ``Continuing Review After Study Approval''
(September 1998, Office of Health Affairs, Food and Drug
Administration). To enhance human subject protection and reduce
regulatory burden, the Department of Health and Human Services, Office
for Human Research Protections (OHRP) and FDA have been actively
working to harmonize the Agencies' regulatory requirements and guidance
for human subject research. This guidance document was developed as a
part of these efforts.
    In the Federal Register of January 13, 2010 (75 FR 1790), FDA
announced the availability of the draft guidance of the same title,
dated January 2010. FDA received numerous comments on the draft
guidance. All comments received during the comment period and questions
received by Agency staff related to implementation of the regulations
have been carefully reviewed and, where appropriate, incorporated into
the guidance. Changes from the draft guidance include more detailed
discussion about what should be submitted to assist the IRB in
conducting continuing review, clarification of recommendations
regarding submission of study-wide information for multi-site studies,
discussion of the circumstances in which expedited review procedures
may be used for continuing review, and revised guidance about how
continuing review dates should be determined. In addition, FDA's draft
guidance, ``IRB Continuing Review after Clinical Investigation
Approval'', did not address IRB approval of research with conditions.
Subsequent to OHRP's issuance of its guidance, ``IRB Approval of
Research with Conditions'' (November 2010), FDA received multiple
inquiries and comments recommending that FDA adopt the same policy. In
response to these comments, FDA is including a discussion of IRB
approval of research with conditions in the guidance.
    This guidance is part of the Information Sheet Guidance Initiative,
announced in the Federal Register of February 3, 2006 (71 FR 5861),
which describes FDA's intention to update the process for developing,
issuing, and making available guidances intended for IRBs, clinical
investigators, and

sponsors. Known as ``Information Sheets,'' these guidances have
provided recommendations to IRBs, clinical investigators, and sponsors
to help them fulfill their responsibilities to protect human subjects
who participate in research regulated by the FDA. The Information Sheet
Guidance Initiative is intended to ensure that the Information Sheets
are updated, consistent with the FDA's good guidance practices (GGPs).
As part of the initiative, which will be ongoing, the Agency plans to
rescind Information Sheets that are obsolete, revise and reissue
guidances that address current issues, and develop new guidance
documents as needed.
    The guidance is being issued consistent with FDA's good guidance
practices regulation (21 CFR 10.115). The guidance represents FDA's
current thinking on this topic. It does not create or confer any rights
for or on any person and does not operate to bind FDA or the public. An
alternative approach may be used if such approach satisfies the
requirements of the applicable statutes and regulations.

II. Comments

    Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) either electronic or written comments regarding this
document. It is only necessary to send one set of comments. Identify
comments with the docket number found in brackets in the heading of
this document. Received comments may be seen in the Division of Dockets
Management between 9 a.m. and 4 p.m., Monday through Friday.

III. Electronic Access

    Persons with access to the Internet may obtain the document at
either http://www.regulations.gov or  http://www.fda.gov/ScienceResearch/SpecialTopics/RunningClinicalTrials/GuidancesInformationSheetsandNotices/ucm113709.htm.

    Dated: February 21, 2012.
Leslie Kux,
Acting Assistant Commissioner for Policy.
[FR Doc. 2012-4425 Filed 2-24-12; 8:45 am]
BILLING CODE 4160-01-P